Brain Tumor Committee Minesh Mehta MD July 17

Brain Tumor Committee Minesh Mehta, MD July 17, 2020 11: 15 am – 12: 45 pm ET Advancing Research. Improving Lives. Togethe

About this Webinar Format • Attendees will join in “listen only” mode; only the Zoom host can unmute you. • Your participation is encouraged! – Use the chat for questions and comments – Raise your hand, the Host can unmute you

Your NRG Team for This Session Minesh Mehta, MD Session Chair Manmeet Ahluwalia, MD Chat Moderator Kathryn Okrent Zoom Host Rupesh Kotecha, MD Chat Moderator Treena Davis-Trotman Zoom Co-Host

• Session may be recorded • Unauthorized use of any materials viewed during this session is strictly prohibited • These are working sessions • While we’d love to see you on social media #NRG 2020 @NRGonc, we don’t want to see any session content that isn’t explicitly authorized for such!

Session Agenda 1. Introduction: Clinical trials and NRG/COVID: Mehta 5 min 2. Burri: Pre-operative vs. post-operative SRS for brain metastases a. Present finalized version to Brain Committee (5 min presentation, 5 min discussion) b. Slated to go to Research Strategy at the July meeting 3. Sperduto/Kotecha: Ipilimumab/nivolumab + SRS vs. FSRT for melanoma brain metastases a. Present finalized version to Brain Committee (5 min presentation, 5 min discussion) b. Slated to go to Research Strategy at the July meeting 4. Puduvalli/Gondi: EORTC adult medulloblastoma concept a. Present finalized version to Brain Committee (5 min presentation, 5 min discussion) b. Slated to go to Research Strategy at the July meeting 5. Concepts (all 5 min presentation, 5 min discussion; 10 min total) for review: Review 4 concepts a. Rimas: IDO inhibitor (discuss final design for later submission to RSC, not July) b. Kim: Advanced imaging based GBM RT (discuss final design) c. Riggins/Sengupta: Mebendazole for meningioma d. Aulakh: Concept 1 from ABTC e. Umemura: Concept 2 from ABTC 6. Wrap-up: 5 min